← Back to Clinical Trials
Recruiting NCT06659731

NCT06659731 Quantitative Sensory Testing to Study Pain Perception in Autism

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06659731
Status Recruiting
Phase
Sponsor IRCCS Eugenio Medea
Condition Autism Spectrum Disorder (ASD)
Study Type OBSERVATIONAL
Enrollment 50 participants
Start Date 2024-07-17
Primary Completion 2025-07

Trial Parameters

Condition Autism Spectrum Disorder (ASD)
Sponsor IRCCS Eugenio Medea
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 5 Years
Max Age 17 Years
Start Date 2024-07-17
Completion 2025-07
Interventions
Quantitative Sensory testing (QST)EEG

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims at assess sensory perception, and pain perception, in neurodivergent children and adolescent in the autism spectrum. To achieve this goal, the quantitive sensory testing (QST), a controlled and replicable protocol, will be used, to assess perception in different sensory modalities: heat sensations, mechanical detection threshold and pain threshold. As secondary aim, the cortical processing of thermal painful stimuli will be collected through electroencephalography (EEG) in order to investigate if there are differences in the cortical processing of painful stimuli between clinical sample and control sample, and if it could be associated with differences in the subjective experience between the two groups. Finally, it will be explored the association between such differences, and indexes of psychopathology and dispositional measures.

Eligibility Criteria

Inclusion Criteria for the clinical sample: * Children and adolescent * age between 5 and 17 years old * Autism diagnosis according to DSM-V criteria Inclusion Criteria for the control sample: * healthy children and adolescent (without neurological, and psychiatric, diagnoses) * age between 5 and 17 years old Exclusion Criteria: Comorbidities with (for the clinical sample) or diagnosis of (for the control sample): * peripheral neuropaties; * psychiatric diagnosis as psychosis, * Tourette Syndrome, * neurological diagnoses as epilepsy, * sensory deficit or loss; * genetic diseases

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology